Last reviewed · How we verify

NCT04538820

Dexamethasone Dose for Postoperative Nausea and Vomiting Prophylaxis in Obese Patients

Status unknown Phase 4 Last updated 8 September 2021
What this trial tests

Phase 4 trial testing Dexamethasone 4 mg IV-control in Postoperative Nausea and Vomiting in 150 participants. Status unknown.

Timeline
1 March 2021
Primary endpoint
30 September 2021
30 September 2021

Quick facts

Lead sponsorDiskapi Yildirim Beyazit Education and Research Hospital
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposeprevention
Enrollment150
Start date1 March 2021
Primary completion30 September 2021
Estimated completion30 September 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Diskapi Yildirim Beyazit Education and Research Hospital

Who can join

Adults 18 to 65, female only, with Postoperative Nausea and Vomiting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

compare the effectiveness of different doses of dexamethasone used for postoperative nausea and vomiting prophylaxis in obese patients and in normal weight patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postoperative Nausea and Vomiting

Currently open trials in the same condition.

Other Diskapi Yildirim Beyazit Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04538820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing